HUMAN SERUM AMYLOID-A3 ANTIBODY AND USE THEREOF
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Jul 26, 2012
app pub date -
Aug 16, 2010
filing date -
Oct 2, 2009
priority date (Note) -
Abandoned
status (Latency Note)
![]() |
A preliminary load of PAIR data current through [] has been loaded. Any more recent PAIR data will be loaded within twenty-four hours. |
PAIR data current through []
A preliminary load of cached data will be loaded soon.
Any more recent PAIR data will be loaded within twenty-four hours.
![]() |
Next PAIR Update Scheduled on [ ] |

Importance

US Family Size
|
Non-US Coverage
|
Abstract
The objective of the invention is to prepare an antibody to human SAA3 whose in vivo presence has not yet been identified in humans, thereby revealing the presence of in vivo human SAA3 and the relationship between human SAA3 and disease, and also to provide a method for treating such disease. More specifically our objective is to create an antibody to counter human serum amyloid-A3 and a kit for detecting and measuring human serum amyloid-A3 employing the aforementioned antibody, as well as a therapeutic cancer agent that can be utilized in methods to treat and diagnose cancer.
First Claim
all claims..Other Claims data not available
Family
Country | kind | publication No. | Filing Date | Type | Sub-Type |
---|---|---|---|---|---|
JP | A1 | JPWO2011040133 | Aug 16, 2010 | Patent | Application |
Type : Patent Sub-Type : Application | |||||
DOMESTIC RE-PUBLICATION OF PCT APPLICATION | ヒト血清アミロイドA3抗体およびその利用 | Feb 21, 2013 | |||
EP | A1 | EP2484693 | Aug 16, 2010 | Patent | Application |
Type : Patent Sub-Type : Application | |||||
APPLICATION PUBLISHED WITH SEARCH REPORT | HUMAN SERUM AMYLOID-A3 ANTIBODY AND USE THEREOF | Aug 08, 2012 | |||
WO | A1 | WO2011040133 | Aug 16, 2010 | Patent | Application |
Type : Patent Sub-Type : Application | |||||
INTERNATIONAL APPLICATION PUBLISHED WITH INTERNATIONAL SEARCH REPORT | ヒト血清アミロイドA3抗体およびその利用 | Apr 07, 2011 | |||
CN | A | CN102549014 | Aug 16, 2010 | Patent | Application |
Type : Patent Sub-Type : Application | |||||
UNEXAMINED APPLICATION FOR A PATENT FOR INV. | Human serum amyloid-A3 antibody and use thereof | Jul 04, 2012 |
- 15 United States
- 10 France
- 8 Japan
- 7 China
- 5 Korea
- 2 Other
Patent Owner(s)
Patent Owner | Address | |
---|---|---|
TOKYO WOMEN'S MEDICAL UNIVERSITY | TOKYO 162-8666 |
International Classification(s)

- 2010 Application Filing Year
- A61K Class
- 10962 Applications Filed
- 7633 Patents Issued To-Date
- 69.64 % Issued To-Date
Inventor(s)
Inventor Name | Address | # of filed Patents | Total Citations |
---|---|---|---|
Maru, Yoshiro | Tokyo, JP | 2 | 0 |
# of filed Patents : 2 Total Citations : 0 | |||
Tanaka, Takeshi | Tokyo, JP | 347 | 3882 |
# of filed Patents : 347 Total Citations : 3882 | |||
Terai, Kiyomi | Saitama, JP | 1 | 0 |
# of filed Patents : 1 Total Citations : 0 |
Cited Art Landscape
- No Cited Art to Display

Patent Citation Ranking
- 0 Citation Count
- A61K Class
- 0 % this patent is cited more than
- 13 Age
Forward Cite Landscape
- No Forward Cites to Display

Maintenance Fees
Fee | Large entity fee | small entity fee | micro entity fee | due date |
---|
Fee | Large entity fee | small entity fee | micro entity fee |
---|---|---|---|
Surcharge after expiration - Late payment is unavoidable | $700.00 | $350.00 | $175.00 |
Surcharge after expiration - Late payment is unintentional | $1,640.00 | $820.00 | $410.00 |
Full Text

Legal Events
- No Legal Status data available.

Matter Detail

Renewals Detail
